Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by muscle weakness and caused by pathogenic autoantibodies that bind to membrane proteins at the neuromuscular junction. Most patients have autoantibodies against the acetylcholine receptor (AChR), but a subset of patients have au...
Автори: | Takata, K, Stathopoulos, P, Cao, M, Mané-Damas, M, Fichtner, M, Benotti, E, Jacobson, L, Waters, P, Irani, S, Martinez-Martinez, P, Beeson, D, Losen, M, Vincent, A, Nowak, R, O'Connor, K |
---|---|
Формат: | Journal article |
Опубліковано: |
American Society for Clinical Investigation
2019
|
Схожі ресурси
Схожі ресурси
-
Diagnostic use of autoantibodies in myasthenia gravis.
за авторством: Leite, M, та інші
Опубліковано: (2010) -
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
за авторством: Miriam L. Fichtner, та інші
Опубліковано: (2022-10-01) -
Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
за авторством: Gomez, A, та інші
Опубліковано: (2016) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
за авторством: Miriam L Fichtner, та інші
Опубліковано: (2022-01-01) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
за авторством: Miriam L. Fichtner, та інші
Опубліковано: (2022-01-01)